New weight loss drugs aim to save muscle
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
New weight loss drugs aim to promote muscle growth
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
These Drugs Could Offset the Side Effects of Weight Loss
Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.
Next generation weight loss drugs aim to save muscle
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Factbox-Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Regeneron (NASDAQ: REGN) is testing its drug, trevogrumab, along with Wegovy and another treatment, garetosmab, in a ...
The next battle in the weight-loss drug war is focussed on muscle growth
Doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures ...
U.S. News & World Report3d
Fat, Not Muscle: Drugmakers in Race for Next Weight-Loss Breakthrough
Veru Veru's oral drug ... In a mid-stage study, patients who received the drug along with Wegovy lost 71% less lean, or muscle, mass on average than those who received Wegovy and a placebo ...
pharmaphorum2d
Veru shares plunge despite positive data in obesity trial
Veru's enobosarm is designed to be used in combination with GLP-1 agonist-based obesity drugs – such as Novo Nordisk's blockbuster Wegovy (semaglutide) – to reduce the loss of lean muscle mass ...
The Globe and Mail5d
Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Detailed price information for Veru Inc (VERU-Q) from The Globe and Mail including charting and trades.